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Thymoma is the most common neoplasm of
the thymus, and early-stage tumors carry an
excellent prognosis with 5-year survival rates
over 85% with primarily surgical management.1
However, thymoma has a strong association with
paraneoplastic syndromes, which do not have the
same favorable response to surgery. Paraneoplastic
syndromes are found to persist, worsen, or even
present in the post-thymectomy setting. We
report a case of likely paraneoplastic vasculitis in
the setting of thymoma that presented after
thymectomy.CASE
A previously healthy 60-year-old man presented
to an outside hospital with recurrent pruritic
eruptions in the setting of unintentional weight
loss, diffuse arthralgias, and myalgia. The eruptions
were characterized by pink papules on his trunk and
proximal thighs that resolved within 24 hours with
no hyperpigmentation, clinically consistent with
urticaria. He was treated with prednisone, up to
40 mg daily, and his rash flared when the dose was
tapered. Chest radiograph showed a large
mediastinal mass found to be a stage IIb thymoma.
The mass was excised, and he underwent
postoperative radiation therapy. The patient’s
urticaria improved postoperatively, but he required
prednisone, 10 mg daily, to maintain disease control.
Biopsy results of the transient urticarial rash were
consistent with urticaria with no signs of vasculitis.
Three months postoperatively, the patient noted
worsening of his rash and persistence of lesions
beyond 24 hours. He presented to our departmentthe Department of Dermatology,a Division of Rheumatolo-
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admixed with hyperpigmented ecchymotic patches
(Fig 1). Punch biopsies were performed, and the
patient was started on cetirizine and ranitidine and
maintained on prednisone. Histology found a
predominantly neutrophilic infiltrate, leukocytocla-
sis, and occasional eosinophils. Dermal hemorrhage
was present as was focal vessel wall damage. The
histologic features were consistent with an early
lesion of urticarial vasculitis (Fig 2).
Laboratory results found a modest elevation in
creatinine to 1.1 mg/dL from a baseline of 0.8 (to
convert to micromoles per liter, multiply by 88.4), an
erythrocyte sedimentation rate of 30 mm/h,
C-reactive protein level of 3.3 mg/dL (to convert to
nanomoles per liter, multiply by 9.524), and low C3
and C4 levels of 82mg/dL and 14mg/dL, respectively
(to convert to grams per liter, multiply by 0.01).
Thyroid-stimulating hormone and free thyroxine
levels were within normal limits. Serologic testing
results were positive for perinuclear antineutrophil
cytoplasmic antibody (pANCA) with antimyeloper-
oxidase specificity and negative for rheumatoid
factor, anti-Ro, anti-La, and hepatitis B and C.
Microscopic hematuria prompted a retroperitoneal
ultrasound scan, which found no hydronephrosis or
calculi, and renal biopsy was deferred because of
lack of proteinuria, dysmorphic red blood cells, andJAAD Case Reports 2016;2:153-5.
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Fig 1. MPA clinical photographs. Blanchable, edematous, erythematous papules admixed with
hyperpigmented ecchymotic patches.
Fig 2. MPA histologic findings. A, Low-power view shows focal dermal hemorrhage and
dermal inflammation predominantly composed of neutrophils with occasional eosinophils.
B, High-power view shows the inflammation and focal extravasated erythrocytes and
leukocytoclasis and focal vascular wall damage. (A and B, hematoxylin-eosin stain; original
magnifications: A, 3100; B, 3200.)
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evidence of thymoma recurrence.
Prednisone was increased to 60 mg/d, and
dapsone (50 mg/d) was added with improvement
in eruption and resolution of his arthralgia and
microscopic hematuria. Methotrexate (20 mg/wk)
was added as a second steroid-sparing agent with
plans to taper the patient’s prednisone.
COMMENT
Thymomas are frequently associated with
autoimmune phenomena. Myasthenia gravis is
the most common, and others include limbic
encephalitis, neuromyotonia, and polymyositis,
among many others.2 The coincident onset of
symptoms and diagnosis of thymoma in this patient
raises high suspicion for a paraneoplastic etiology.
The most likely explanation for our patient’s pre-
sentation is that he suffered 2 unique paraneoplasticsyndromes: urticaria and microscopic polyangiitis
(MPA). The patient’s rash at initial presentation had
clinical features of urticaria, such as characteristic
morphology, resolution within 24 hours without
hyperpigmentation, and response to steroids, with
supportive histopathology. In contrast, the rash that
developed after thymectomy was clinically and
histologically consistent with MPA, defined by the
Chapel Hill Clinical Criteria as a small vessel
necrotizing vasculitis without immune deposits.3
Antineutrophil cytoplasmic antibodyepositive sero-
logies are not necessary for the diagnosis of MPA, but
the presence of pANCA with anti-myeloperoxidase
specificity strongly supports the diagnosis. Other
features consistent with MPA include the patient
demographics (older age, white race), inflammatory
arthritis, and the clinical progression from prodrome
of constitutional symptoms to skin lesions and signs of
kidney damage.
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reported case of MPA associated with thymoma.
The patient was a 50-year-old white man whose
presenting symptoms were arthralgias and skin
eruption, similar to those of our patient. The skin
findings were described as an ‘‘evanescent
maculopapular rash’’ and did not undergo biopsy.
Although thymectomy seems to have precipitated
the onset of MPA in our patient, the previous case
report describes severe exacerbation of MPA in the
post-thymectomy setting. The patient’s disease
course featured prominent renal and pulmonary
manifestations of MPA, and there were no further
skin findings.4
A second possible explanation is that MPA is the
unifying diagnosis responsible for both the urticarial
and the purpuric rash. This explanation would be
consistent with the previously reported case of
exacerbation of MPA in the post-thymectomy
setting,4 as our patient’s condition also declined in
the months after surgery. One theory to explain this
phenomenon is immune dysregulation caused by
imbalance of T-regulatory cells.
However, although cutaneous manifestations are
present in about 50% of patients with MPA, our
patient’s initial urticaria is not a characteristic finding.
Urticaria has only to our knowledge been reported
in 1 case, in which a 79-year-old man with
pANCA-positive vasculitis had urticarial erythema.
Biopsy of his lesions found neutrophils and
fragmentation of nuclei in the dermal perivascular
regions with negative immunofluorescence studies.5The biopsy of our patient’s initial eruption did not
show vasculitis, but steroid treatment could explain
the lack of active vessel damage at that time.
A third explanation to consider is progression
from common urticaria to urticarial vasculitis (UV).
Hyperpigmentation and prolonged eruptions are
typical of UV, and arthralgias and kidney damage
are associated as well. UV can be associated
with hypocomplementemia, and our patient had
mildly decreased complement levels with the
decrease corresponding to clinical progression.
Hypocomplementemic UV is not typically associated
with antineutrophil cytoplasmic antibodies.
Clinicians should be aware of the potential
association of cutaneous vasculitis with thymoma
and of the possibility that paraneoplastic eruptions
may present after thymectomy.
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